Join us for an open dialogue with several game-changers from Nue Life who will discuss their treatment, findings, and a call for mainstream adoption of this method of care.

Many in the United States are benefitting from ketamine treatment, reporting that major symptoms of depression are reduced after just a few doses in a clinical setting. This medicine, when used with intention and care, can bring a new level of mental wellness to one’s life.

However, psychedelics like ketamine have a long history of stigma, resulting in reluctance from prescribers to adopt this type of treatment. The lack of ketamine prescribers presents a bottleneck to the mainstreaming of psychedelic treatment within the mental health infrastructure.

NueLife—a team of dedicated physicians, expert technologists, and compassionate clinicians—delivers responsive, personalized ketamine therapy in the comfort of their clients’ homes. Research shows that of their 650 patients with treatment-resistant depression and anxiety, approximately 2/3rds saw over a 50% reduction in symptoms after just six ketamine sessions.

Panelists:

Lauren Marchefka – Board-certified family nurse practitioner and member of the senior medical team at Nue Life.

Lynn-Marie Morski – President of the Psychedelic Medicine Association, host of the Psychedelic Medicine Podcast, and Medical Director for Nue Life Health.

Ben Medrano – Medical Director of Nue Life Medical Group. Additionally, Ben works in patient care as Medical Director of Field Trip NYC and DC clinics while providing direct care within his private practice.

Host:

David Drapkin – The Director of Operations and Strategic Growth at Psychedelics Today. Additionally, he is a licensed clinical social worker and seasoned mental health and addiction practitioner.

When it comes to patient populations, veterans are among the most challenging to treat. Many return from service with debilitating conditions, including PTSD, treatment resistant depression, traumatic brain injury and chronic pain.

The costs – both financial and human – of military service are extreme. Recent studies suggest that between 2001 and 2050, the total costs of caring for veterans of the post-9/11 wars will reach between $2.2 and $2.5 trillion. It is estimated that on average, 44 veterans die in the United States every day from suicide.

Can psychedelics promise new hope to veterans suffering in sub-standard models of care? How can psychedelics be used to create a better standard of care for veterans and their families?

Join us in discussion with three North American veterans (Arron Victory, Apex Labs; Jesse Gould, Heroic Hearts; and Justin LaPree, Heroic Path to Light) on the eve of Remembrance Day (Canada) and Veterans Day (U.S.) on topics including:

• How psychedelics are currently being used by veteran populations, both above and underground
• The current standard of care for veterans post-service, the strengths of the current system and where it falls short
• Grassroots community efforts to support veterans and first responders in North America
• How biotech is working to create alternate psychedelic treatment options for veteran populations
• Ongoing and upcoming clinical trials to study the effects of psychedelics on veterans
• How governments are responding to calls for psychedelic access for veterans
• Successes veterans and their families are finding in psychedelic therapies

A growing number of mental health professionals are enrolling in training programs in psychedelic-assisted psychotherapy, but don’t know know to implement PAP in their practice. Join cofounder and CEO Jonathan Sabbagh to learn more about how Journey Clinical enables licensed psychotherapists to deliver PAP in your own practice, starting with Ketamine-Assisted Psychotherapy. Jonathan will explain the Journey Clinical collaborative care model and technology platform, and share how their member psychotherapists successfully deliver KAP in their practice as an adjunct to therapy.

Jonathan is the Co-Founder and CEO of Journey Clinical, the leading telehealth platform expanding access to Psychedelic-Assisted Psychotherapy. A serial entrepreneur, Jonathan built his career in finance, spending over two decades working for hedge funds and building businesses in Switzerland and NYC. After receiving a difficult diagnosis of PTSD and extreme burnout, Jonathan left the world of finance to focus on his mental health, during which he personally experienced the transformative benefits of plant medicine and Ketamine-Assisted Psychotherapy (KAP).

Ultimately, Jonathan’s personal and professional journey motivated him to found Journey Clinical in 2020, the #1 platform in the US that enables licensed mental health professionals to deliver KAP at scale. Learn more at www.JourneyClinical.com.

Please note that registrations (names, email addresses) are shared with the webinar collaborator.

Join us for “Traditional and Modern Perspectives on Healing,” part two of a two-part series in collaboration with the Indigenous Medicine Conservation Fund (IMC Fund). The IMC Fund was co-created for the sovereign protection and regeneration of the medicines, ecologies & traditional knowledge Indigenous communities have honored for thousands of years.

In this webinar, we will be looking at the importance of respecting traditional Indigenous cultures and practices. This panel brings together professionals with both traditional and modern training to discuss these medicines and how they are being worked with at this time by different groups and in different demographics, and to learn together in an exchange between equals. Building on part one of the series, panelists will discuss the differences between appreciation and appropriation, and share their experience in the field and on the ground.

Please note that registrations (names, email addresses) are shared with the webinar collaborator.

Join us for “Appreciation vs. Appropriation,” part one of a two-part webinar series in collaboration with the Indigenous Medicine Conservation Fund (IMC Fund). The IMC Fund was co-created for the sovereign protection and regeneration of the medicines, ecologies & traditional knowledge Indigenous communities have honored for thousands of years.

In this webinar series, we will be discussing the importance of respecting traditional Indigenous cultures and practices. As the psychedelic renaissance forges on, it is important to emphasize conserving and supporting traditional knowledge and we are urging having these conversations. While the IMC Fund focuses on biocultures that have ancestral practices with plants such as ayahuasca, iboga and peyote, we know that all indigenous cultures have rich traditions that deserve respect, and that land and territory issues at the community level are linked to mental health and climate change outcomes globally.

How do we ensure the original holders of these sacred medicines are respected and uplifted in this search for our collective healing? Together we can hold a respectful and constructive dialogue and exchange that isn’t extractive, and instead appreciates rather than appropriates an exchange between equals.

This webinar is FREE to attend, however, we highly recommend making a contribution via Grow Medicine (https://growmedicine.com/), a project and donation platform of the IMC Fund.

Speakers:

Sutton King, MPH – Co Director of the Urban Indigenous Collective
Anahí Ochoa – Director of the Intercultural Yaqui Medicine Clinic
Mona Polacca – Leader in the Native American revitalization movement
Miriam Volat, MS – Co-Director of the Riverstyx Foundation

Join the father of modern microdosing, Dr. James Fadiman, Ph.D, and Adam Bramlage, microdosing coach and educator, as they answer your questions on the history, science and best practices for microdosing psychedelics. Bramlage will present a 15 minute crash course on Microdosing 101, before a 45 minute Q and A with James Fadiman, Ph.D. Bramlage and Fadiman are the lead educators of Psychedelics Today’s newest online course, “The Microdosing Masterclass.” (www.psychedeliceducationcenter.com/p/microdosing-master-class)

James Fadiman is an American writer known for his research on microdosing psychedelics. He and Robert Frager co-founded the Institute of Transpersonal Psychology, which later became Sofia University, where he was a lecturer in psychedelic studies. Fadiman is a proponent of microdosing. He writes and lectures on the topic and collects anecdotal reports from those who practice it.

Adam Bramlage is Founder/CEO of Flow State Micro, a functional mushroom company, and microdosing education platform. Bramlage works one on one with clients to optimize their microdosing experience. He’s helped hundreds of people, from professional athletes to people suffering from addiction and depression, achieve results through microdosing in his private practice.

Europe’s leading conference on psychedelic science and therapy. ICPR is returning for its fifth edition in Amsterdam, the Netherlands, with speakers Paul Stamets, David Nutt, Amanda Feilding, Roland Griffiths, Rick Doblin, and more.

Are you interested in learning more about ICPR? Head to the ICPR conference page for more detailed information and to register for tickets.

On Thursday September 15 at 1p ET, Court Wing of REMAP Therapeutics and Joe Moore of Psychedelics Today will discuss a recently published paper – “Microdosing psilocybin for chronic pain: a case series”.

Microdosing psilocybin for chronic pain: a case series by Matthew Lyes, Kevin H Yang, Joel Castellanos, Timothy Furnish

Link to register.

Are you interested in attending our live Navigating Psychedelics course?

Do you have questions?

Are you looking to level up your offerings in the expanding field of psychedelic-assisted support and want to know how to get there?

Visit the links below to register for your preferred Q&A date and time:

Tuesday, November 22nd 5:00pm MST

Past episodes

Links

Religious Practice Under Oregon Measure 109 by Jon Dennis, Esq.

An interview Jon did with Psanctuary, a psilocybin church out of Kentucky, about the proposal

Psychedelica Lex: Jon Dennis, Esq. Gives an Oregon Psilocybin Update – Measure 109

Psychedelichealth.co.uk: Psychedelics industrial complex could put psychedelic religions in jeopardy

Are you interested in attending one of our upcoming Navigating Psychedelics course offerings?

Do you have questions about our course that you would like answered?

Are you looking to level up your offerings in the expanding field of psychedelic-assisted support and want to know how to get there?

Join Joe Moore Friday July 2nd at 9:00am MST in this special Q&A to get all of your questions answered, so you can dive into a course that levels you up in your career of psychedelic integration support.

Register here!

Join Joe Moore and Tim Cools to discuss Psychedelic Experience. We’ll be taking questions from the audience to discuss how the website has been up and running since 2017, their recruitment and safety protocols and much more.

This special webinar will take place May 27, 2021 at 10:00AM MST

About Tim Cools

Tim is a conscious entrepreneur and psychedelic coach. After experiencing the profound transformational power of Ayahuasca in 2015, he realized his purpose is to advocate safe and responsible use of psychedelic plants and medicines: this is how Psychedelic Experience was born! He has over two decades of professional experience developing industrial-grade software in various industries, including smart homes, energy, payroll and logistics. In 2018, Tim re-trained himself as a psychedelic integration coach and guide, hosting legal psychedelic sessions and retreats in the Netherlands. Tim’s interests are software architecture, psychedelics and plant medicine, non-dualism, mindfulness, and helping people to reduce their suffering and improve their well-being.

Psychedelics Today is turning 5 years old!

On Thursday, May 13th, we’re celebrating 5 whole years of making Psychedelics Today and you are all invited to come celebrate with us! 

We’re hosting a live, virtual birthday party on 5/13 starting at 7:30 pm EST on Twitch. We’ll start with a conversation between Joe, Kyle, and our newest edition, Michelle, on the origins of Psychedelics Today, how Joe & Kyle met, why they wanted to start a psychedelic podcast and media company, how they created their Navigating Psychedelics course, and so much more! We’ll also be opening it up to questions from the audience, so if you’ve been meaning to ask us something, Thursday evening is your chance!

Then after about an hour, we’ll be winding down (or ramping up) with a live vinyl DJ set from dr. bouchard. So mark your calendars and get ready to celebrate our birthday with us! It’s totally FREE and guaranteed to be a super chill evening full of psychedelic insight, music, and more!